Showing results (1211-1220 of 1,240) with videos related to
Sort By:
Pageof 124
JCO Precision Oncology|January 15, 2026
Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder AnalysisSusanne A Gatz, Julia Glade-Bender, Andrew D J Pearson, et al.Physical Review Letters|August 16, 2006
Measurement of the Ec.m. = 184 keV resonance strength in the 26gAl (p, gamma)27 Si reactionC Ruiz, A Parikh, J José, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Quality assessment of genetic markers used for therapy stratificationI M Ambros, J Benard, M Boavida, et al.The Journal of Pediatrics|September 15, 2024
A National Simulation-Based Study of Pediatric Critical Care Transport Teams PerformanceErin E Montgomery, Ingrid M Anderson, Daniel J Scherzer, et al.Physical Review Letters|October 10, 2006
Precision branching ratio measurement for the superallowed beta+ emitter 62Ga and isospin-symmetry-breaking corrections in A>or=62 nucleiB Hyland, C E Svensson, G C Ball, et al.Journal of the National Cancer Institute|August 25, 2025
International neuroblastoma risk group consortium: a model of a networking for rare cancersSusan L Cohn, Wendy B London, Gudrun Schleiermacher, et al.European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC studyFernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.European Journal of Cancer (Oxford, England : 1990)|February 18, 2019
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in childrenAndrew D J Pearson, Nicole Scobie, Koenraad Norga, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2020
Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN StudyKeith Holmes, Ulrike Pötschger, Andrew D J Pearson, et al.European Journal of Cancer (Oxford, England : 1990)|July 13, 2020
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe NeuroblastomaLucas Moreno, Giuseppe Barone, Steven G DuBois, et al.Pageof 124